48 participants
A Study to Investigate the Pharmacokinetics (PK) and Safety and to Provide Proof of Mechanism of Alogabat in Children and Adolescents Aged 5-17 Years With Angelman Syndrome (AS) With Deletion Genotype.
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-12-04
- Start Date:
- 2023-07-27
- Completion:
- 2025-12-02
Conditions
- Angelman Syndrome
Interventions
- DRUG
No Results Yet